Test Code CATPA Catecholamine, Endocrine Study, Plasma
Ordering Guidance
This test is not the first-tier test for pheochromocytoma, as plasma catecholamine levels may not be continuously elevated. For the recommended first-tier laboratory test for pheochromocytoma, order either:
-PMET / Metanephrines, Fractionated, Free, Plasma
-METAF / Metanephrines, Fractionated, 24 Hour, Urine
Do not perform the test on patients withdrawing from legal or illegal drugs known to cause rebound plasma catecholamine release during withdrawal (see Cautions for additional information).
Specimen Required
Patient Preparation:
1. Discontinue drugs that release epinephrine, norepinephrine, or dopamine, or hinder their metabolism, for at least 1 week before obtaining the specimen (see Cautions for details). If this is not possible for medical reasons, contact the laboratory and discuss whether a shorter drug-withdrawal period may be possible in a particular case.
2. Unless the purpose of the measurement is drug monitoring, discontinue any epinephrine, norepinephrine, or dopamine injections/infusions for at least 12 hours before specimen draw.
3. The patient must refrain from eating, using tobacco, and drinking caffeinated beverages for at least 4 hours before the specimen is collected.
Supplies: Catecholamine tubes containing EDTA-sodium metabisulfite solution (T066) (tubes have a 6-month. expiration time)
Collection Container/Tube:
Preferred: 10-mL Catecholamine tubes containing EDTA-sodium metabisulfite solution
Acceptable: 6-mL Catecholamine tubes containing EDTA-sodium metabisulfite solution
Submission Container/Tube: Plastic vial
Specimen Volume: 3 mL per collection
Collection Instructions:
1. Drawing from a catheter is required.
2. Calm the patient by giving complete instructions and reassurance regarding the procedure.
3. Insert an indwelling intravenous catheter. Flush with 3 mL of saline, using positive pressure.
4. Have the patient rest for 30 minutes in the supine position in a quiet room.
5. At the end of the 30 minutes, withdraw and discard a minimum of 3 mL of blood to remove the saline out of the catheter.
6. If provocative sampling (eg, standing specimen) is required, perform provocative maneuver immediately after obtaining supine specimen. Obtain standing specimen immediately.
7. For each specimen, draw blood into the chilled EDTA-sodium metabisulfite 10-mL tube.
8. Specimen must remain at refrigerated temperature during processing and transport.
9. Separate plasma in a refrigerated centrifuge within 30 minutes of draw.
10. Freeze specimen immediately.
Secondary ID
33859Useful For
Diagnosis of pheochromocytoma and paraganglioma in specimens collected from individuals in both supine and standing positions, as an auxiliary test to fractionated plasma and urine metanephrine measurements
Diagnosis and follow-up of patients with neuroblastoma and related tumors, as an auxiliary test to urine vanillylmandelic acid and homovanillic acid measurements
Evaluation of patients with autonomic dysfunction/failure or autonomic neuropathy
Profile Information
Test ID | Reporting Name | Available Separately | Always Performed |
---|---|---|---|
CTP0 | Catecholamine, Fract, Supine, P | No | Yes |
CTP10 | Catecholamine, Fract, Standing, P | No | Yes |
Method Name
Liquid Chromatography Tandem Mass Spectrometry (LC-MS/MS) Includes unconjugated norepinephrine, epinephrine, and dopamine.
Reporting Name
Catecholamine, Endocrine Study, PSpecimen Type
Plasma EDTA MetaSpecimen Minimum Volume
2 mL per collection
Specimen Stability Information
Specimen Type | Temperature | Time | Special Container |
---|---|---|---|
Plasma EDTA Meta | Frozen | 28 days |
Reject Due To
Gross hemolysis | Reject |
Gross lipemia | OK |
Gross icterus | OK |
Reference Values
NOREPINEPHRINE
Supine: 70-750 pg/mL
Standing: 200-1,700 pg/mL
EPINEPHRINE
Supine: Undetectable-110 pg/mL
Standing: Undetectable-140 pg/mL
DOPAMINE
<30 pg/mL (no postural change)
Day(s) Performed
Monday through Friday
Report Available
2 to 6 daysPerforming Laboratory
Mayo Clinic Laboratories in RochesterTest Classification
This test was developed and its performance characteristics determined by Mayo Clinic in a manner consistent with CLIA requirements. It has not been cleared or approved by the US Food and Drug Administration.CPT Code Information
82384 x 2
LOINC Code Information
Test ID | Test Order Name | Order LOINC Value |
---|---|---|
CATPA | Catecholamine, Endocrine Study, P | 95056-8 |
Result ID | Test Result Name | Result LOINC Value |
---|---|---|
33862 | Norepinephrine, Supine | 1601-4 |
33865 | Norepinephrine, Standing | 17368-2 |
33866 | Epinephrine, Standing | 95054-3 |
33863 | Epinephrine, Supine | 1465-4 |
33864 | Dopamine, Supine | 95053-5 |
33867 | Dopamine, Standing | 95055-0 |